SamanTree Medical Highlights Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at the 2024 SABCS

“These outstanding results underscore the potential of the Histolog Scanner to enhance oncologic surgical outcomes significantly,” said Olivier Delporte, CEO of SamanTree Medical. “By enabling real-time, high-resolution tissue microstructure assessments during BCS, our technology addresses a critical unmet need, reducing reoperation rates and improving patient outcomes.